Clorox Plans Presentation at Barclays Conference Following Q4 Report and GOJO Integration

Clorox (NYSE: CLX) has scheduled a presentation at the Barclays Global Consumer Staples Conference following the release of its fourth-quarter and full-year fiscal 2026 results and publication of its fiscal 2027 outlook. The presentation is set for August 19, 2026, coming roughly two weeks after the company announced its financial results on August 3.

Context and Strategic Positioning

In its earnings release for the quarter ending June 30, 2026, Clorox reported that net sales decreased 2% to $1.95 billion, though the acquisition of GOJO (Purell) contributed approximately 10 percentage points to this figure. Organic sales fell 13%, largely due to a year-over-year comparison with heightened shipments related to the company’s ERP transition in the prior period. Gross margin compressed to 41.3% from 46.5%, burdened by inventory step-up related to the GOJO acquisition, ERP transition impacts, and elevated manufacturing and logistics costs. Adjusted EPS dropped 42% to $1.66 per share, also reflecting integration expenses. Looking ahead, Clorox expects fiscal year 2027 net sales to grow 13%–14%, including a 9.5-point boost from GOJO and 3.5%–4.5% organic growth.

The Barclays presentation presents an opportunity for Clorox management to provide further detail on GOJO’s integration, operational adjustments, and growth prospects, and to reiterate its fiscal 2027 guidance to the investor community.

Why It Matters

Investor and analyst interest in Clorox has centered on the successful integration of GOJO, post-ERP normalization of demand patterns, and margin recovery. The Barclays conference, a key gathering for consumer staples professionals, will offer Clorox leadership a timely platform to reinforce its narrative around these strategic developments.

Next Steps to Monitor

• Highlights and investor reaction from Clorox’s presentation on August 19, 2026.
• Updates on the pace of GOJO integration and its contribution to sales and margins.
• Any revised guidance or commentary regarding the recovery of organic demand and margin stabilization.

Clorox’s scheduled event at the Barclays Global Consumer Staples Conference provides a pivotal moment to assess whether the company is on track to realize fiscal 2027 expectations and fully capitalize on its expanded health and hygiene platform.